India Position as Global Vaccine Manufacturer and Supplier
Source:PIB ↗
ఇది ఎందుకు ముఖ్యం
This article highlights India's strategic position as the 'Pharmacy of the World' and a leading global supplier of vaccines by volume, which is vital for questions relating to indigenous technology development, biotechnology advancements, and global health diplomacy under GS Paper III.
సారాంశం
Union Minister Dr Jitendra Singh announced that India has firmly established itself as the world's largest vaccine producer and global supplier by volume, driven by advances in biotechnology, indigenous R&D, and affordable manufacturing capabilities that support global health security.
ముఖ్య అంశాలు
- India is currently the world\'s largest vaccine producer and a major global supplier by volume.
- Union Minister Dr Jitendra Singh highlighted India\'s emergence as a global biotechnology hub and pharmaceutical powerhouse.
- The growth is powered by robust public-private partnerships, indigenous R&D, and cost-effective manufacturing capabilities.
- India played a critical role in global health security during pandemics by supplying vaccines globally, particularly to low- and middle-income countries.
ముఖ్యమైన పదాలు
Indian Bioeconomy
The aggregate economic value generated through biotechnology-related commercial activities, research, and manufacturing in India, encompassing biopharmaceuticals, bio-services, bio-agriculture, and bio-industrial sectors.
UPSC context
UPSC Prelims/Mains (GS Paper III): Important for topics related to economic growth, biotechnology, science and technology applications, and industrial development.
BioE3 Policy (Biotechnology for Economy, Environment and Employment)
An initiative by the Government of India designed to foster high-performance biomanufacturing across sectors like green energy, bio-based chemicals, and smart agriculture to support sustainable growth.
UPSC context
UPSC Prelims/Mains (GS Paper III): Crucial for questions on biotechnology policies, sustainable development, environmental governance, and green technology.
Ministry of Science and Technology
The branch of the Union Government responsible for formulating and administering rules, regulations, and laws relating to scientific research, technological development, and biotechnology promotion in India.
UPSC context
UPSC Prelims/Mains (GS Paper II/III): Important for understanding institutional frameworks, governance of scientific research, and implementation of technology policies in India.
ప్రిలిమ్స్ ఉచ్చు
India is the world's largest vaccine producer and supplier by value and volume.
Aspirants often confuse value (where Western pharma leads in revenue) with volume (where India leads due to cost-effective generics).
అనుసంధానమైన స్థిర భావనలు
What are India's key institutional frameworks and international bodies for vaccine regulation and pandemic preparedness?
- Regulatory Authority: CDSCO is the national regulatory body under the Ministry of Health and Family Welfare responsible for approval of new drugs and clinical trials.
- CEPI Membership: CEPI is a global partnership launched in Davos to develop vaccines to stop future epidemics; India is a founding member.
- THSTI Role: THSTI (Translational Health Science and Technology Institute) under DBT focuses on translational research in medicine and biotechnology.
అంతర-అంశ నమూనాలు
Biopharma exports & WTO TRIPS flexibilities
India's vaccine dominance relies heavily on TRIPS flexibilities and compulsory licensing debates at the WTO to ensure affordable exports to the Global South.
National Bioeconomy & S&T policy integration
Bioeconomy growth heavily intersects with National Biotechnology Development Strategy and Department of Biotechnology funding under the Ministry of Science and Technology.
Expect a statement-based question linking India's bioeconomy target (USD 150B+) with its 60% global vaccine volume share and WHO routine supply role.
అనుసంధాన PYQలు · 2
అనుసంధాన PYQలు · 2
- 2022MainsGS3
What is the basic principle behind vaccine development ? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines ?
- 2022PrelimsGS1
In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements : 1. The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform. 2. Sputnik V vaccine is manufactured using vector based platform. 3. COVAXIN is an inactivated pathogen based vaccine. Which of the statements given above are correct?
